SCAI releases official position statement on optimal percutaneous interventional therapy for complex coronary artery disease

May 14, 2020

WASHINGTON - The Society for Cardiovascular Angiography and Interventions (SCAI) has published a position statement addressing optimal percutaneous coronary intervention (PCI) treatment of patients with complex coronary artery disease (CAD).

The position statement was presented today during the SCAI 2020 Scientific Sessions Virtual Conference and published in SCAI's official journal, Catheterization and Cardiovascular Interventions.

While complex PCI has not yet been fully defined, this patient group presents both complex anatomic lesions and clinical parameters including advanced age, frailty, comorbidities, compromised hemodynamic status, depressed ventricular function and concomitant valvular disease. These factors increase both the procedural complexity of percutaneous coronary intervention (PCI) and the risk of adverse patient outcomes.

"Over the last several years, there has been an increase in the anatomic and physiologic complexity of patients presenting to the catheterization lab. During that time, a multitude of tools have been developed to aid defining and treating this group when percutaneous revascularization is indicated," said Robert F. Riley, MD, FSCAI, member of the document writing group, and research and medical director, Complex Coronary Therapeutics Program at The Christ Hospital. "However, this population has been incompletely defined up to this point and there is a need to provide a contemporary evidence-based document that specifically addresses aspects of complex PCI in this patient group."

In the position statement, a multidisciplinary group of experts provide a state-of-the art update addressing evidence regarding PCI in patients with complex clinical and anatomical features and provide procedural guidance to achieve optimal outcomes for this challenging patient group. The document examines pre-procedural assessment of coronary anatomical complexity and higher-risk clinical features and interventional treatment of complex CAD.

"This document further complements the concomitantly published SCAI statement on the performance of PCI in ambulatory surgical centers. Together, we hope these documents will provide guidance on best practices and the performance settings for PCI across the spectrum of clinical and anatomical complexity," Riley concludes.
-end-
About the Society for Cardiovascular Angiography and Interventions

The Society for Cardiovascular Angiography and Interventions (SCAI) is a professional member organization representing 5,000 invasive and interventional cardiologists in approximately 75 nations. SCAI's mission is to promote excellence invasive and interventional cardiovascular medicine through physician education and representation, and advancement of quality standards to enhance patient care. For more information about SCAI, visit http://www.scai.org and http://www.secondscount.org. Follow @SCAI on Twitter for the latest heart health news.

Society for Cardiovascular Angiography and Interventions

Related Coronary Artery Disease Articles from Brightsurf:

Researchers use multi-ancestry comparison to refine risk factors for coronary artery disease
An international group led by researchers from the RIKEN Center for Integrative Medical Sciences have used a combination of genome-wide association analysis--or GWAS--and a trans-ancestry comparison of different GWAS studies, to come up with a more accurate predictor of coronary artery disease based on genetic factors.

Oral radiography can reveal chronic coronary artery disease
A study found a link between carotid artery calcification observable in radiographs and coronary artery disease as well as several oral infections.

A new strategy to counter insulin damage in coronary artery disease
By studying blood vessel tissue from 674 patients, a research team has discovered how insulin contributes to the dysfunction of blood vessels in atherosclerosis, one of the most common chronic health conditions worldwide.

3D fusion imaging improves coronary artery disease diagnosis
A new technique that combines CT and MRI can bolster coronary artery disease diagnosis and help to define appropriate treatment for patients suffering from the disease, according to a new study.

Associations between vaspin levels and coronary artery disease
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0565, Lutfu Askin, Okan Tanriverdi, Hakan Tibilli and Serdar Turkmen from the Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey consider associations between vaspin levels and coronary artery disease.

Waist size, not body mass index, may be more predictive of coronary artery disease
For years, women have been told that weight gain could lead to heart disease.

Women with coronary artery wall thickness at risk for heart disease
The thickness of the coronary artery wall as measured by MRI is an independent marker for heart disease in women, according to a new study.

SPIE journal reports advances in use of 3D models in assessing coronary artery disease
In an article published in SPIE's Journal of Medical Imaging (JMI), researchers announce critical advances in the use of 3D-printed coronary phantoms with diagnostic software, further developing a non-invasive diagnostic method for Coronary Artery Disease (CAD) risk assessment.

E-cigarettes linked to heart attacks, coronary artery disease and depression
Concerns about the addictive nature of e-cigarettes -- now used by an estimated 1 out of 20 Americans -- may only be part of the evolving public health story surrounding their use, according to data being presented at the American College of Cardiology's 68th Annual Scientific Session.

Is guideline-recommended therapy for coronary artery disease more likely in Medicare Advantage?
Medicare Advantage is Medicare's managed-care alternative to traditional fee-for-service Medicare.

Read More: Coronary Artery Disease News and Coronary Artery Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.